Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2213-2220

  Levendag, Peter C ^a   Schmitz, Paul I ^a   Jansen, Peter P ^a   Eijkenboom, Wilhelmina M ^a   Visser, Andries G ^a   Kolkman Deurloo, Inger Karine ^a   Sipkema, Dick ^a   Visch, Leo L ^a   Senan, Suresh ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; DISEASE CONTROL; DOSE RESPONSE; HUMAN; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECURRENT DISEASE; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 0031801369     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2213     Document Type: Article

References (65)

1. Wei WI, Sham JST: Cancer of the nasopharynx, in Myers EN, Suen JY (eds): Cancer of the Head and Neck (3 ed). Philadelphia, PA, Saunders, 1996, pp 277-293
2. Lee AWM, Poon YF, Foo W, et al: Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23:261-270, 1992
3. Taifu L: Trends in the clinical management of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 23:469-471, 1992
4. Teo PML, Yu P, Lee WY, et al: Significant prognosticators after primary radiotherapy in 903 non-disseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36:291-304, 1996
5. Ingersoll L, Woo SY, Donaldson SS, et al: Nasopharyngeal carcinoma in the young: A combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 19:881-887, 1990
6. Tang SGJ, Lin FJ, Chen MS, et al: Prognostic factors of nasopharyngeal carcinoma: A multivariate analysis. Int J Radiat Oncol Biol Phys 19:1143-1149, 1990
7. World Health Organization: Histological typing of upper respiratory tract tumors, in International Histological Classification of Tumors No. 19. Geneva, Switzerland, World Health Organization, 1978, pp 32-33
8. Shanmngaratman K: Histological typing of nasopharyngeal carcinoma, in The G, Ito Y. (eds): Nasopharyngeal Carcinoma: Etiology and Control. Lyon, France, International Agency for Research on Cancer, 1978, pp 3-12
9. Sham JST, Choy D, Wei WI: Nasopharyngeal carcinoma: Orderly neck node spread. Int J Radiat Oncol Biol Phys 19:929-933, 1990
10. Hermanek P, Sobin LH: TNM Classification of Malignant Tumours. UICC International Union Against Cancer, Geneva (ed 4). New York, NY, Springer-Verlag, 1987, pp 1-197
11. American Joint Committee on Cancer: Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992, pp 34-35
12. Roth SL, Bertram G, Sack H: Carcinoma of the nasopharynx -Comparison of the UICC and Ho clinical staging systems. Klin Wochenschr 67:74-85, 1989
13. Grandi C, Boracchi P, Mezzanotte G, et al: Analysis of prognostic factors and proposal of a new classification for nasopharyngeal cancer. Head Neck 12:31-40, 1990
14. Wei WI, Ho CM, Yuen PW, et al: Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch Otolaryngol Head Neck Surg 121:638-642, 1995
15. Perez CA, Devineni VR, Marcial-Vega V, et al: Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 23:271-280, 1992
16. Pryzant RM, Wendt CD, Delclos L, et al: Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 22:941-947, 1992
17. Bedwinek JM, Perez CA, Keys DJ: Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer 45:2725-2729, 1990
18. Sham JST, Wei WI, Kwan WH, et al: Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy. Cancer 65:216-220, 1990
19. Wang CC: Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 14:5-8, 1991
20. Chong VFH, Yoke-Fun F: Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 202:463-469, 1997
21. Davis WL, Harnsberger HR, Smoker WRK, et al: Retropharyngeal space: Evaluation of normal anatomy and diseases with CT and MR imaging. Radiology 174:59-64, 1990
22. Olmi P, Cellai E, Chiavacci A, et al: Computed tomography in nasopharyngeal carcinoma: Part I: T-stage conversion with CT staging. Int J Radiat Oncol Biol Phys 19:1171-1175, 1990
23. Yu KH, Teo WY, Leung SF, et al: Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: A study based on CT scanning. Clin Oncol 6:167-171, 1994
24. Kutcher GJ, Fuks ZY, Brenner HJ, et al: Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 21:169-182, 1991
25. Kuchnir FT, Heffron J, Myrianthopoulos LC, et al: Beam's-eye-view aided treatment planning for a nasopharyngeal lesion: A case report. Med Dosim 14:231-235, 1989
26. Vikram B, Mishra UB, Strong EW, et al: Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 11:1455-1459, 1985
27. Teo PML, Lee WY, Yu P: The prognostic significance of parapharyngeal tumor involvement in nasopharyngeal carcinoma. Radiother Oncol 39:209-221, 1996
28. Sham JST, Choy D: Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 13:298-310, 1991
29. Mingchen Z: Results of radiotherapy in nasopharyngeal cancer. A retrospective comparison of split-course and continuous-course treatment schedules. Acta Oncol 28:77-80, 1989
30. Yan JH, Qin DX, Hu YH, et al: Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): Are higher doses beneficial? Int J Radiat Oncol Biol Phys 16:1465-1469, 1988
31. Chang JT, See LC, Tang SGJ, et al: The role of brachytherapy in early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 36:1019-1024, 1996
32. Mesic JB, Fletcher GH, Goepfert H: Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7:447-453, 1981
33. Dimery IW, Peters LJ, Goepfert H, et al: Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 11:1919-1928, 1993
34. Tannock IF, Payne DG, Cummings BJ, et al: The Princess Margaret Hospital Head and Neck Cancer Group. Sequential chemotherapy and radiation for nasopharyngeal cancer: Absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 5:629-634, 1987
35. International Nasopharyngeal Study Group: VUMCA I trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥ N2M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 35:463-469, 1996
36. Chan ATC, Teo PML, Leung TWT, et al: A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33:569-577, 1995
37. Garden AS, Lippman SM, Morrison WH, et al: Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys 36:1005-1012, 1996
38. Al-Sarraf M, McLaughlin PW: Nasopharynx carcinoma: Choice of treatment. Int J Radiat Oncol Biol Phys 33:761-763, 1995
39. Goldsmith BJ, Rosenthal SA, Wara WM, et al: Optic neuropathy after irradiation of meningeioma. Radiology 185:71-76, 1992
40. Young WC, Thornton AF, Gebarski SS, et al: Radiation-induced optic neuropathy: Correlation of MR imaging and radiation dosimetry. Radiology 185:904-907, 1992
41. Parsons JT, Bova FJ, Fitzgerald CR, et al: Radiation optic neuropathy after megavoltage external-beam irradiation: Analysis of time-dose factor. Int J Radiat Oncol Biol Phys 30:755-763, 1994
42. Jiang GL, Tucker SL, Guttenberger R, et al: Radiation-induced injury to the visual pathway. Radiother Oncol 30:17-25, 1994
43. Erickson BA, Wilson F: Nasopharyngeal brachytherapy. Am J Clin Oncol 16:424-443, 1993
44. Teo PML, Kwan WH, Yu P, et al: A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumor control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients. Clin Oncol 8:160-166, 1996
45. Teo PML, Leung SF, Choi P, et al: Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. Br J Radiol 67:181-185, 1994
46. Leung TWT, Tung SY, Wong VYW, et al: High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma. Acta Oncol 35:43-47, 1996
47. Choy D, Sham JST, Wei WI, et al: Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 25:505-512, 1993
48. Leung TWT, Wong VYW, Tung SY, et al: The importance of three-dimensional brachytherapy treatment planning for nasopharyngeal carcinoma. Clin Oncol 9:35-40, 1997
49. Levendag PC, Schmitz PIM, Jansen PP, et al: Fractionated high dose rate & pulsed dose rate brachytherapy - First clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 38:497-506, 1997
50. Levendag PC, Peters R, Meeuwis CA, et al: A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx. Radiother Oncol 45:95-98, 1997
51. Levendag PC, Visser AG, Kolkman-Deurloo IKK, et al: HDR brachytherapy with special reference to cancer of the nasopharynx, in Mould RF, Battermann JJ, Martinez AA, et al (eds): Brachytherapy From Radium to Optimization. Veenendaal, the Netherlands, Nucletron International BV, 1994, pp 121-131
52. International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU Report 50, 1993
53. Levendag PC, Nowak PJCM, Van der Sangen MJC, et al: Local tumor control in radiation therapy of cancers in the head and neck. Am J Clin Oncol 19:469-477, 1996
54. Levendag PC, Ravasz LA, Terhaard CHJ, et al: T3 squamous cell carcinoma of the larynx treated by a split-course radiation protocol. A multiinstitutional study. Am J Clin Oncol 16:509-518, 1993
55. Fowler JF: Why shorter half-times of repair lead to greater damage in pulsed brachytherapy. Int J Radiat Oncol Biol Phys 26:353-356, 1993
56. Brenner DJ, Hall FJ: Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 20:181-190, 1991
57. Collins SL, Dougherty M, Stupp R, et al: Head and neck, nasopharynx, in Abeloff MD, Armitage JO, Lichter AS, et al (eds): Clinical Oncology. New York, NY, Churchill Livingstone, 1995, pp 995-996
58. Kwong DLW, Sham JST, Choy D: The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients. Int J Radiat Oncol Biol Phys 30:1029-1036, 1994
59. Niemierko A, Goitein M: Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 29:140-147, 1993
60. Cmelak AJ, Cox RS, Adler JR, et al: Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 37:997-1003, 1997
61. Al-Sarraf M, LeBlanc M, Giri PGS, et al: Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. Proc Am Soc Clin Oncol 15:313, 1996 (abstr) (publication in press, 1998)
62. Gaspar LE, Qian C, Kocha WI, et al: A phase I/II study of external-beam radiation, brachy-therapy and concurrent chemotherapy in localised cancer of the esophagus (RTOG 92-07): Preliminary toxicity report. Int J Radiat Oncol Biol Phys 37:593-599, 1997
63. Munro AJ: An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91, 1995
64. Rosenthal DI, Pistenmaa DA, Glatstein E: A review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys 28:315-320, 1994
65. Paccagnella A, Orlando A, Marchiori C, et al: Phase III trial of induction chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994